for its manufacturing plants, opening up significant opportunities for the company to expand its reach in both emerging and regulated markets. Additionally, the company has filed the necessary ...

The medtech industry (companies that are manufacturing and developing medical ... Figure 3: Pharmaceutical R&D investment in Europe* Pharma investment in R&D in Europe shows that Switzerland ...

He has also said he will soon declare tariffs on the pharma industry ... Large drugmakers have global manufacturing footprints, mainly in the U.S., Europe and Asia, and moving more production ...

The automotive industry might follow suit shortly without the input Argentina has ceased to be a tire-manufacturing country as labor conflicts resulted in the closing of all three plants ...

Mike Ryan, general manager of Europe and Asia Pacific at EVERSANA, spoke with Pharmaceutical Executive about the unique challenges market access challenges pharma companies face in Europe.

Denmark is one of Europe's largest pharma and biotech ... loss drug sales derived from U.S. plants, instead pointing to the firm's "very significant" manufacturing set-up in the U.S. 'No.

President Trump wants to bring pharmaceutical manufacturing back to the ... industry’s supply chain are China, India and Europe. For example, plants in China and India make nearly all of the ...

The country has always been a major hub in Europe for manufacturing, with many larger pharma companies holding a presence on the Emerald Isle for a number of years. One of the companies with a ...

But the U.S. depends on medicines partly produced in Europe that bring in hundreds ... to spend at least $27 billion on four new manufacturing plants in the U.S., but many drugmakers would find ...

according to more than a half dozen pharma industry sources with direct knowledge of the discussions. Sign up here. Some are signalling a willingness to expand manufacturing in the United States ...